The WVU Cancer Institute 32nd Annual Spring Gala was an opportunity to honor some very special individuals. During an “An Evening of Hope, Innovation and Partnership” Cancer Institute leadership presented the Crystal Ribbon Award to Pam Bakalarski, Greg Darby, Hannah Hazard Jenkins, MD and William Petros, PharmD. The award was designed by a glass artisan with Glass Dimensions of Tamarack to encompass and inspire the three attributes of hope, innovation and partnership.
William Petros, PharmD, former interim director at the Cancer Institute and associate director for anticancer drug development, praised Pam Bakalarski for her advocacy of clinical trials research. “She’s devoted her professional career to focusing on improving the lives of cancer patients; today tens of millions of people are receiving better treatment through clinical trials.” He added that Pam is also an inspiration because she is a cancer patient and survivor.
Denver Allen, major gifts director for the Cancer Institute, lauded Greg Darby calling him a very powerful force in promoting and supporting the efforts of WVU Basketball Coach Bob Huggins to advance cancer clinical trials. “He gives because he cares,” Allen said.
WVU Cancer Institute Director Richard Goldberg, MD praised Hannah Hazard Jenkins for her commitment to public service. “Her commitment in this area, and especially to the underserved in West Virginia, is in her DNA,” Dr. Goldberg said, noting her grandfather’s public service role and adding that Hannah is a West Virginian by parentage and birth.
The Cancer Institute surprised Dr. Petros with a Crystal Ribbon. “Bill not only maintained stability of the Cancer Institute while serving as interim director, but also moved us forward,” Deputy Director Laura Gibson, PhD said. “The respect that all of his colleagues have for him was always obvious and was reflected in the appreciation that people had for his leadership and advice. He is a truly valued colleague and friend.”
Petros, who also holds the Mylan Chair of Pharmacology, has been named the Gates Wigner Dean of the WVU School of Pharmacy and will assume that role on June 1.
WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2017 Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2010 to 2014.
The West Virginia Breast and Cervical Cancer Screening Program (WVBCCSP), a program of WVU Cancer Institute Cancer Prevention and Control, has designated January 12 as Wear Teal Day in observance of cervical cancer awareness across the state. Each year in West Virginia, approximately 97 women are diagnosed and 37 women die of cervical cancer, according to the West Virginia Cancer Burden Report for 2017. The publication points out that while these numbers are small, West Virginia ranks in the top five for both cervical cancer incidence and mortality when compared with other states, and more than half of the women with cervical cancer in the state are diagnosed at an advanced stage. The good news is that most cervical cancer can be prevented by screening with Pap and Human Papillomavirus (HPV) tests and HPV vaccination. The WVBCCSP helps uninsured and underinsured women gain access to free or low-cost cervical cancer and breast cancer screening services.
This six-week series will equip participants with mindfulness tools and techniques geared towards achieving greater focus and resiliency, whether academically or in the workplace.